Doctor profile · Federal record
Dr. Michelle Simmons, FNP-C
Family Nurse Practitioner (CMS: Nurse Practitioner) · Primary Care Nurse Practitioner · Dallas, TX
- NPI 1306215660
- Accepts Medicare
- 11 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3600 Gaston Ave Ste 360
Dallas, TX 752461903
(214) 820-3971 - Mailing address
-
2424 Wrexham Dr
McKinney, TX 750712655
Credentials & registration
- NPI registered
- September 2015 — 11 yrs on file
- Profile last updated
- November 26, 2024
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Texas #AP128663
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1306215660. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,029
Distinct HCPCS
8
Medicare allowed
$75,501
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 229 | 117 | $110 | |
80307 |
Testing for presence of drug, by chemistry analyzers | 228 | 118 | $60 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 174 | 99 | $105 | |
98980 |
Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month | 119 | 35 | $42 | |
98977 |
Device supply with scheduled recording and transmission for remote monitoring of musculoskeletal system, per 30 days | 114 | 33 | $43 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 98 | 82 | $71 | |
98981 |
Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, each additional 20 minutes per calendar month | 35 | 20 | $33 | |
98975 |
Set-up and patient education for remote monitoring of therapy | 32 | 32 | $16 |
In context: peer comparison
Among 168 peers in Dallas Family Nurse Practitioner, average services per provider: 416. This provider delivers 2.5× the peer median.Open Payments
Industry payments received
All-time total
$1,815
Transactions
74
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | 25 | $324.80 | |
| Abbvie INC. | 10 | $259.29 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | 11 | $173.00 | |
| Abbott Laboratories | 1 | $153.43 | |
| Sk Life Science, INC. | 1 | $124.10 | |
| Forte Bio-Pharma LLC | 6 | $119.44 | |
| Amgen INC. | 1 | $104.18 | |
| Kyowa Kirin, INC. | 1 | $95.72 | |
| Averitas Pharma INC. | 3 | $83.06 | |
| Pfizer INC. | 3 | $67.53 | |
| Medtronic, INC. | 2 | $56.12 | |
| Spr Therapeutics, INC | 4 | $45.55 | |
| Ibsa Pharma INC. | 2 | $42.59 | |
| Valinor Pharma, LLC | 2 | $36.21 | |
| Scilex Pharmaceuticals INC. | 2 | $33.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
14
Patients
0
Total drug cost
$7,855
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Calcipotriene | Generic | 14 | 0 | $7,855 |
Hospital affiliations
Frequently asked questions
What is Dr. Michelle Simmons's medical specialty?
Dr. Michelle Simmons practices Family Nurse Practitioner in Dallas, TX.
Where does Dr. Michelle Simmons practice?
Dr. Michelle Simmons practices at 3600 Gaston Ave Ste 360, Dallas, TX 752461903. Office phone: 2148203971.
What is Dr. Michelle Simmons's NPI?
Dr. Michelle Simmons's National Provider Identifier (NPI) is 1306215660, issued by NPPES.
Does Dr. Michelle Simmons accept Medicare assignment?
Yes. Dr. Michelle Simmons accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michelle Simmons commonly perform?
Top Medicare-reported procedures in 2023: Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS G0480); Testing for presence of drug, by chemistry analyzers (HCPCS 80307); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.